InMed Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INM and other ETFs, options, and stocks.

About INM

InMed Pharmaceuticals, Inc. engages in developing small molecule drug candidates targeting the CB1/CB2 receptors. It operates through the InMed Pharma and BayMedica Commercial segments.

CEO

Eric A. Adams

CEOEric A. Adams

Employees

Employees13

Headquarters

Vancouver, British Columbia

HeadquartersVancouver, British Columbia

Founded

1981

Founded1981

Employees

Employees13

INM Key Statistics

Market cap

4.91M

Market cap4.91M

Price-Earnings ratio

-0.24

Price-Earnings ratio-0.24

Dividend yield

—

Dividend yield—

Average volume

139.38K

Average volume139.38K

High today

$2.15

High today$2.15

Low today

$2.02

Low today$2.02

Open price

$2.10

Open price$2.10

Volume

76.90K

Volume76.90K

52 Week high

$8.27

52 Week high$8.27

52 Week low

$1.72

52 Week low$1.72

People also own

Based on the portfolios of people who own INM. This list is generated using Robinhood data, and it’s not a recommendation.